Combined extensive liver resections in patients with locally advanced hepatocellular cancer – clinical cases
https://doi.org/10.17709/2409-2231-2020-7-2-14
Abstract
Currently the main way of curable treatment of hepatocellular carcinomas (HCC)* is a liver resection. Candidates for surgery are patient with good score of liver function (Child-Pugh A group), without destruction of great vessels and distant metastases. Hemihepatectomy is associated with a high risk of postoperative liver failure (including portal hypertension, cirrhosis, portal vein thrombosis). This reason leads to premature failure of the operation. According to current clinical guidelines, system therapy is more suitable, despite of the lack of reliable data on its effectiveness in such clinical situations. The presented cases may support the selection of advanced hemihepatectomy as a treatment for hepatocellular cancer C stage BCLC classification.
About the Authors
D. V. Sidorov
P.A.Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre
Russian Federation
Russian Federation
Dmitrii V. Sidorov – Dr. Sci. (Med.), head of the department of abdominal oncology
3 2nd Botkinskiy travel, Moscow 125284
SPIN: 1670-3690
AuthorID: 642999
M. V. Lozhkin
P.A.Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre
Russian Federation
Russian Federation
Mikhail V. Lozhkin – Cand. Sci. (Med.), leading researcher of the department of abdominal oncology
3 2nd Botkinskiy travel, Moscow 125284
SPIN: 4982-5909
AuthorID: 652950
L. O. Petrov
A.F.Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological Center
Russian Federation
Russian Federation
Leonid O. Petrov – Cand. Sci. (Med.), head of department of radiation and surgical treatment of abdominal diseases
4 Korolev str., Obninsk 249036
SPIN: 4559-3613
AuthorID: 665865
A. G. Isaeva
A.F.Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological Center
Russian Federation
Russian Federation
Aisha G. Isaeva – assistant research fellow
4 Korolev str., Obninsk 249036
SPIN: 7121-6391
AuthorID: 945036
M. S. Gusakova
P.A.Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre
Russian Federation
Russian Federation
Mariya S. Gusakova – resident physician
3 2nd Botkinskiy travel, Moscow 125284
References
1. Steger U, Kellersmann A, Germer CT. Hemihepatektomie. Zentralblatt für Chirurgie. 2016; 141(03): 253–255. https://doi.org/10.1055/s-0042–102535
2. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC), Korea. 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver. 2019; (3): 227–299. https://doi.org/10.5009/gnl1902
3. Bruera G, Cannita K, Giordano AV, Manetta R, Vicentini R, Carducci S, et. al. Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice. Biomed Res Int. 2014; 2014: 806391. https://doi.org/10.1155/2014/806391
4. Dimitroulis D, Damaskos C, Valsami S, Davakis S. Garmpis N, Spartalis E, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017 Aug 7; 23(29): 5282–5294. https://doi.org/10.3748/wjg.v23.i29.5282
5. Marreroa JA, Kudob M, Bronowickic J P. The Challenge of Prognosis and Staging for Hepatocellular Carcinoma. The Onologist, 2010. https://doi.org/10.1634/theoncologist.2010-S4–23
6. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg. 2002; 194(5): 592–602. https://doi.org/10.1016/s1072–7515(02)01163–8
7. Liau K H, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, et al. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer. 2005 Nov 1; 104(9): 1948–1955. https://doi.org/10.1002/cncr.21415
8. Omata M, Cheng A L, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017 Jul; 11(4): 317–370. https://doi.org/10.1007/s12072–017–9799–9
9. Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct;29 Suppl 4: iv238–iv255. https://doi.org/10.1093/annonc/mdy308
10. Jin S, Fu Q, Wuyun G. Wuyun T. Management of post-hepatectomy complications. World J Gastroenterol. 2013 Nov 28; 19(44): 7983–7991. https://doi.org/10.3748/wjg.v19.i44.7983
11. W, Paik Y H, Cho J Y, Lim HY, Ahn JM, Sinn DH, et al. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: treatment outcome and prognostic factors. J Hepatol. 2015 May; 62(5): 1112–1121. https://doi.org/10.1016/j.jhep.2014.12.009
12. Kim SE, Lee HC, Kim KM, Lim Y S, Chung Y H, Lee YS, et al. Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center. Korean J Hepatol. 2011 Jun; 17(2): 113–119. https://doi.org/10.3350/kjhep.2011.17.2.113
13. Jiang J F, Lao Y C, Yuan B H, Yin J, Liu X, Chen L, et al. Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges. Oncotarget. 2017 May 16; 8(20): 33911–33921. https://doi.org/10.18632/oncotarget.15411
14. NCCN Version 1.2019 Hepatobiliary Cancers, 2018 Dec 17. Доступно по: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary_blocks.pdf
15. Steven A Curley, Carlton C Barnett, Abdalla K, Amit Singal G. Management of potentially resectable hepatocellular carcinoma: Prognosis, role of neoadjuvant and adjuvant therapy, and posttreatment surveillance. Review current through: Mar 2019. Доступно по: https://www.uptodate.com/contents/management-of-potentially-resectable-hepatocellular-carcinoma-prognosis-role-of-neoadjuvant-and-adjuvant-therapy-and-posttreatment-surveillance
Review
For citations:
Sidorov D.V., Lozhkin M.V., Petrov L.O., Isaeva A.G., Gusakova M.S. Combined extensive liver resections in patients with locally advanced hepatocellular cancer – clinical cases. Research and Practical Medicine Journal. 2020;7(2):154-163. (In Russ.) https://doi.org/10.17709/2409-2231-2020-7-2-14
Views:
1065
Email this article 